Dermatology · Brooklyn, NY
NPI
1215295480
Since 2012
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1938 Coney Island Ave
Brooklyn, NY, 11230
Phone (718) 905-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$261K
15,087 services
Medicare patients, 2024
672
Average age 78
Drug cost, 2024
$1.4M
4,295 prescriptions
Company payments, 2025
$1,836
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Natallia V Fiadorchanka was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 10,200 times for 36 patients. In total Natallia V Fiadorchanka billed 15,087 services in 67 codes, and Medicare paid $261K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-31.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 10,200 | 36 | $1.28 | $13K |
| 17003 Destruction Skin Lesion | Office | 2,439 | 289 | $6.27 | $15K |
| 99213 Office E&M - Established | Office | 618 | 413 | $80.43 | $50K |
| 17000 Destruction Skin Lesion | Office | 491 | 309 | $53.30 | $26K |
| 99212 Office E&M - Established | Office | 213 | 167 | $50.79 | $11K |
| 11102 Skin Biopsy | Office | 193 | 174 | $88.33 | $17K |
| 99203 Office E&M - New | Office | 169 | 169 | $103.03 | $17K |
| 17110 Destruction Skin Lesion | Office | 152 | 127 | $103.24 | $16K |
| 17004 Destruction Skin Lesion | Office | 69 | 44 | $156.73 | $11K |
| 11103 Skin Biopsy | Office | 69 | 45 | $48.06 | $3,316 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 68 | 32 | $0.72 | $49.01 |
| 96574 Skin | Office | 47 | 33 | $245.83 | $12K |
| 11900 Skin | Office | 42 | 33 | $39.37 | $1,654 |
| 12032 Wound Repair - All Levels | Office | 33 | 29 | $284.12 | $9,376 |
| 17311 Mohs Surgery | Office | 32 | 31 | $627.37 | $20K |
By year: 2022 $392K for 23,617 services; 2023 $356K for 16,293 services; 2024 $261K for 15,087 services.
Medicare prescription drug claims, 2024
In 2024, the drug Natallia V Fiadorchanka prescribed most often to Medicare patients was Ketoconazole, with 1,045 prescriptions and refills. In total Natallia V Fiadorchanka wrote 4,295 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 1,045 | 1,062 | 338 | $20K |
| Ammonium Lactate Generic | 465 | 485 | 184 | $9,263 |
| Mupirocin Generic | 333 | 335 | 245 | $1,785 |
| Clindamycin Phosphate Generic | 275 | 276 | 129 | $12K |
| Mometasone Furoate Generic | 244 | 246 | 155 | $3,919 |
| Nystatin Generic | 219 | 223 | 82 | $3,523 |
| Clotrimazole Generic | 204 | 207 | 68 | $5,526 |
| Clobetasol Propionate Generic | 179 | 179 | 106 | $12K |
| Hydrocortisone Generic | 109 | 112 | 85 | $643 |
| Triamcinolone Acetonide Generic | 105 | 119 | 76 | $1,518 |
| Betamethasone Dipropionate Generic | 87 | 87 | 48 | $2,043 |
| Ibuprofen Generic | 60 | 60 | 58 | $90.43 |
| Metronidazole Generic | 55 | 56 | 20 | $2,266 |
| Nyamyc Nystatin | 53 | 53 | 20 | $1,584 |
| Valacyclovir Valacyclovir Hcl | 53 | 53 | 26 | $1,324 |
Brand drugs: 359 claims; generic drugs: 3,936 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Natallia V Fiadorchanka $1,836 ($1,836 in general payments such as food, travel and fees) from 14 companies. The largest payer was LEO Pharma Inc. with $464.
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 16 | $464 |
| Abbvie Inc. ABBV | 12 | $248 |
| Amgen Inc. AMGN | 6 | $174 |
| Incyte Corporation INCY | 6 | $142 |
| Janssen Biotech, Inc. JNJ | 5 | $123 |
| Biofrontera Inc. | 5 | $96.24 |
| Lilly USA, LLC LLY | 3 | $85.88 |
| Pfizer Inc. PFE | 3 | $83.83 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $80.92 |
| Arcutis Biotherapeutics, Inc. ARQT | 3 | $75.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.